{"id":"0cd6f1ad-7b10-59ca-98d5-f1a5749bf29e","stable_key":"fcc4fa9c-4dc8-5566-b780-1a486c4d3e72:alcohol-naltrexone-depot","predicate":"reduces","statement":"Long-acting injectable naltrexone reduced heavy drinking in a randomised controlled trial in alcohol dependence, with acceptable tolerability.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"307f1727-3eb2-5e33-9542-48659e246445","mechanism_event_label":"A monthly injection of the same blocker worked too.","subject":{"id":"375e6237-216e-593b-a94a-7050e70cfa00","slug":"naltrexone","display_name":"Naltrexone","entity_type_key":"drug"},"object":{"id":"98327061-a71f-5f7e-8773-700398c2845a","slug":"drinking-days","display_name":"Proportion of heavy drinking days","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"307f1727-3eb2-5e33-9542-48659e246445","stable_key":"fcc4fa9c-4dc8-5566-b780-1a486c4d3e72:alcohol-naltrexone-depot-event","event_type":"observed_intervention","label":"A monthly injection of the same blocker worked too.","description":"Long-acting injectable naltrexone reduced heavy drinking in a randomised controlled trial in alcohol dependence, with acceptable tolerability.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"a8e083df-39ef-5dd0-b7cd-cad77e1b6022","slug":"alcohol-craving","display_name":"Alcohol craving and dependence severity","entity_type_key":"cellular_process"},"role":"affected_process","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"375e6237-216e-593b-a94a-7050e70cfa00","slug":"naltrexone","display_name":"Naltrexone","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"98327061-a71f-5f7e-8773-700398c2845a","slug":"drinking-days","display_name":"Proportion of heavy drinking days","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/alcohol-research/15811981.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"bb7a465c529de6ca90435bf684f771315d916f418979902fd0af0a7d712eaa3f\", \"start_char\": 0, \"end_char\": 2211, \"text_sha256\": \"bb7a465c529de6ca90435bf684f771315d916f418979902fd0af0a7d712eaa3f\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomised controlled trial of long-acting injectable naltrexone","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Monthly injectable naltrexone versus placebo","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A large randomised trial of a depot formulation, which removes the adherence problem of daily dosing.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Alcohol research collection; topical membership is not evidence of a direct clinical effect, and ethanol is recorded separately from the acetaldehyde it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"ethanol","display_name":"Ethanol","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A monthly injection of the same blocker worked too.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[alcohol-p15811981] Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15811981/ DOI: 10.1001/jama.293.13.1617","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Whole body","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"0dec3e94-06a2-5a2f-8fc4-b34522d53d3c","evidence_kind":"source_excerpt","locator":"Lines 618-629","start_line":618,"end_line":629,"excerpt":"### alcohol-naltrexone-depot\nLong-acting injectable naltrexone reduced heavy drinking in a randomised controlled trial in alcohol dependence, with acceptable tolerability.\nCondition category: normal\nnutrient_topic: Alcohol research collection; topical membership is not evidence of a direct clinical effect, and ethanol is recorded separately from the acetaldehyde it becomes.\nplain_language: A monthly injection of the same blocker worked too.\norganism: Human\ntissue_or_cell_type: Whole body\nexperimental_model: Randomised controlled trial of long-acting injectable naltrexone\nlimitations: A large randomised trial of a depot formulation, which removes the adherence problem of daily dosing.\nexposure: Monthly injectable naltrexone versus placebo\nevidence_span: {\"source_cache\": \"artifacts/alcohol-research/15811981.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"bb7a465c529de6ca90435bf684f771315d916f418979902fd0af0a7d712eaa3f\", \"start_char\": 0, \"end_char\": 2211, \"text_sha256\": \"bb7a465c529de6ca90435bf684f771315d916f418979902fd0af0a7d712eaa3f\"}\n[alcohol-p15811981] Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15811981/ DOI: 10.1001/jama.293.13.1617","model_system":"Randomised controlled trial of long-acting injectable naltrexone","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [alcohol-p15811981] Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15811981/ DOI: 10.1001/jama.293.13.1617","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4b310db0-1387-548c-9e3d-6d2ed634b2cd","stable_key":"import-fcc4fa9c-4dc8-5566-b780-1a486c4d3e72","title":"Alcohol: ethanol clearance, acetaldehyde, the channels it binds, organ injury and nutrient collisions (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"cb7e8dc390e8bf302cd5e230cadff6ce9847b4aad8a3691a308964d93ba59a85","revision_id":"4b344e1e-4129-579c-a058-50262b03f9a8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}